• Aurora Cannabis Inc ACB.TO is expected to show a rise in quarterly revenue when it reports results on February 5 for the period ending December 31 2024

• The Leduc Alberta-based company is expected to report a 21.6% increase in revenue to C$78.302 million from C$64.42 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Aurora Cannabis Inc is for a loss of 10 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Aurora Cannabis Inc is $32.00​, above​ its last closing price of $3.65. ​​​

This summary was machine generated February 3 at 13:34 GMT. All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)